拓普集團(601689.SH):“拓普轉債”預計滿足轉股價格修正條件
格隆匯1月5日丨拓普集團(601689.SH)公佈,公司於2022年7月14日公開發行的25億元可轉換公司債券(以下簡稱“可轉債”、“拓普轉債”),本次觸發轉股價格修正條件的期間從2022年12月13日起算,截至2023年1月5日收盤,公司股票在連續17個交易日中已有10個交易日的收盤價低於初始轉股價格71.38元/股的85%,若未來13個交易日內有5個交易日公司股票價格繼續滿足相關條件的,將可能觸發“拓普轉債”的轉股價格修正條款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.